COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus

Coronavirus Guidance for NIH Applicants and Grantees: https://grants.nih.gov/grants/natural_disasters/corona-virus.htm

Dr. Donald Wright

Dr. Donald Wright

Health Science Administrator



Biography

Division:
Division of Translational and Clinical Sciences DTCS
IRG:
Surgical Sciences, Biomedical Imaging & Bioengineering SBIB
Study Section:
Imaging Probes and Contrast Agents IPCA

Dr. Donald Scott Wright received his Ph.D. in chemistry from the University of Cincinnati and he has over 50 publications. Before joining NIH, he held the following leadership positions within the pharmaceutical industry: section director of pharmacokinetics/drug metabolism at Parke-Davis, director of pharmaceutical chemistry at Covance, director of pharmaceutical analysis at Insmed, and director of research and development and chromatographic sciences at PPD. His areas of expertise include pharmacokinetics and drug metabolism, pharmaceutical chemistry, and bioanalytical chemistry of small and large molecules in preclinical and clinical pharmaceutical development.